Infection with MERS-CoV causes lethal pneumonia in the common marmoset.
Infection with MERS-CoV causes lethal pneumonia in the common marmoset.
复制标题
DOI:
10.1371/journal.ppat.1004250
复制
发表时间:
2014-08
期刊:
影响因子:
6.7
通讯作者:
Munster VJ
中科院分区:
文献类型:
--
作者:
Falzarano D;de Wit E;Feldmann F;Rasmussen AL;Okumura A;Peng X;Thomas MJ;van Doremalen N;Haddock E;Nagy L;LaCasse R;Liu T;Zhu J;McLellan JS;Scott DP;Katze MG;Feldmann H;Munster VJ
The availability of a robust disease model is essential for the development of countermeasures for Middle East respiratory syndrome coronavirus (MERS-CoV). While a rhesus macaque model of MERS-CoV has been established, the lack of uniform, severe disease in this model complicates the analysis of countermeasure studies. Modeling of the interaction between the MERS-CoV spike glycoprotein and its receptor dipeptidyl peptidase 4 predicted comparable interaction energies in common marmosets and humans. The suitability of the marmoset as a MERS-CoV model was tested by inoculation via combined intratracheal, intranasal, oral and ocular routes. Most of the marmosets developed a progressive severe pneumonia leading to euthanasia of some animals. Extensive lesions were evident in the lungs of all animals necropsied at different time points post inoculation. Some animals were also viremic; high viral loads were detected in the lungs of all infected animals, and total RNAseq demonstrated the induction of immune and inflammatory pathways. This is the first description of a severe, partially lethal, disease model of MERS-CoV, and as such will have a major impact on the ability to assess the efficacy of vaccines and treatment strategies as well as allowing more detailed pathogenesis studies. The development of vaccines and treatment strategies is aided by robust animal disease models that accurately depict the illness that is observed in humans. Here we describe a new, improved model for MERS-CoV using the common marmoset, whereby the severe, and even lethal, illness that has been observed in many human cases is recapitulated. Prior to the development of this model, the only available animal models for MERS-CoV infection were the rhesus macaque and a mouse model that requires adenovirus-transduced expression of the human version of the protein required for virus entry. The rhesus macaque model more closely mimics the mild to moderate disease observed in some patients—mainly those without significant comorbidities. The increased severity of illness in the common marmoset model is an important advance in the ability to evaluate potential therapeutic agents against MERS-CoV, as discrimination between successfully treated and control animals should be more apparent. In addition, the closer models recapitulate the disease observed in humans, the more likely findings can be eventually translated into use in humans.
登录
查看更多内容
影响因子:
5.4
作者:
Niemeyer, Daniela;Zillinger, Thomas;Mueller, Marcel A.
通讯作者:
Mueller, Marcel A.
DOI:
10.1002/prot.10550
发表时间:
2003-01-01
期刊:
PROTEINS-STRUCTURE FUNCTION AND GENETICS
影响因子:
--
作者:
Petrey, D;Xiang, ZX;Honig, B
通讯作者:
Honig, B
影响因子:
5.4
作者:
Page, Carly;Goicochea, Lindsay;Frieman, Matthew
通讯作者:
Frieman, Matthew
影响因子:
14.9
作者:
McCarthy DJ;Chen Y;Smyth GK
通讯作者:
Smyth GK
影响因子:
6.4
作者:
Gralinski LE;Bankhead A 3rd;Jeng S;Menachery VD;Proll S;Belisle SE;Matzke M;Webb-Robertson BJ;Luna ML;Shukla AK;Ferris MT;Bolles M;Chang J;Aicher L;Waters KM;Smith RD;Metz TO;Law GL;Katze MG;McWeeney S;Baric RS
通讯作者:
Baric RS